There’s never been a better time to put the amazing capabilities of artificial intelligence to work in pharma marketing. Intouch VP of Innovation, Abid Rahman talks about the what, how and why - read on to learn more.
Whether it's being paired with an MRI scanner to cut scan time, defeating the best gamers at strategy, or helping investors make decisions, artificial intelligence (AI) is making headlines daily. But where does pharma fit in? The buzz around AI can often be overwhelming, with little indication of how to
From the massive amounts of useful customer-generated data to the exponential growth in computing power to cheaper, faster data storage and the development of deep neural networks, artificial intelligence (AI) is getting easier and easier to implement. But how does AI rank in the minds of pharmaceutical executives?
Justin Chase, Intouch EVP of innovation and media, recently sat down to talk with MM&M senior editor Larry Dobrow about the evolution of Intouch, how it has embraced innovation from day one, his own arrival at the agency to build the innovation practice, and how Intouch has applied its AI
It's still early days for artificial intelligence (AI) in the pharma and healthcare space. So much depends on navigating the regulatory environment, yet great strides are being made ... they're just not quite as sexy as, say, a chatbot or what IBM once promised Watson would be. To learn more
Google recently noted that four out of five people "say digital video helps them learn new things," and for understanding things like artificial intelligence (AI) and where it sits on the Gartner Hype Cycle, video is the go-to teaching format. The Gartner Hype Cycle is published annually, and the
Intouch and Veeva collaborated to provide a dive deep into best practices and actionable tips for understanding artificial intelligence and machine learning, setting the stage for successful integration of AI and ML into your marketing strategy, and applying AI in key areas for life sciences organizations.
It’s often difficult to diagnose, develop treatments, or find support as a patient when you’re dealing with something that affects so few people. Artificial intelligence can help bring patients with rare diseases together with treatments and with other patients like themselves.
We talk pretty regularly about artificial intelligence (AI) at Intouch, in part because it permeates nearly every part of our pharma marketing lives these days. But also because we’ve been in the AI game since 2012 -- heck, we even wrote a book about it -- and we’re proud of what our
Medical information (MI) teams are an integral part of every pharmaceutical company’s operations. These teams field questions about medications and devices from healthcare professionals – but also from scientists, patients, and company personnel. When a healthcare professional requests information about a drug or device, that’s when the MI team steps
